Kaolin-Based Activated Coagulation Time Measured by Sonoclot in Patients Undergoing Cardiopulmonary Bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 21, Issue 4, 2007, Pages 524-528

  Ganter, Michael T ^a   Monn, Antoinette ^b   Tavakoli, Reza ^b   Klaghofer, Richard ^c   Zollinger, Andreas ^b   Hofer, Christoph K ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TRIEMLI HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

activated coagulation time; anticoagulation; blood coagulation; cardiopulmonary bypass; heparin; kaolin; Sonoclot analysis

Indexed keywords

APROTININ; BLOOD CLOTTING FACTOR 10A INHIBITOR; HEPARIN; KAOLIN; PROTAMINE;

ACCURACY; ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; DOSE TIME EFFECT RELATION; ELECTIVE SURGERY; FEMALE; HEPARINIZATION; HUMAN; INTERMETHOD COMPARISON; MALE; MEASUREMENT; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE;

AGED; ANTIDIARRHEALS; APROTININ; BLOOD COAGULATION; CARDIOPULMONARY BYPASS; FACTOR XA; FEMALE; HEMOSTATICS; HEPARIN ANTAGONISTS; HUMANS; INFUSIONS, INTRAVENOUS; INTRAOPERATIVE COMPLICATIONS; KAOLIN; MALE; MYOCARDIAL ISCHEMIA; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROTAMINES; SURGICAL PROCEDURES, ELECTIVE; THROMBOSIS; TREATMENT OUTCOME; WHOLE BLOOD COAGULATION TIME;

EID: 34547141685     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2006.12.012     Document Type: Article

References (25)

1. Jones K., Nasrallah F., Darling E., et al. The in vitro effects of aprotinin on twelve different ACT tests. J Extra Corpor Technol 36 (2004) 51-57
2. Despotis G.J., Gravlee G., Filos K., et al. Anticoagulation monitoring during cardiac surgery: A review of current and emerging techniques. Anesthesiology 91 (1999) 1122-1151
3. Prisco D., and Paniccia R. Point-of-care testing of hemostasis in cardiac surgery. Thromb J 1 (2003) 1-10
4. Shore-Lesserson L. Monitoring anticoagulation and hemostasis in cardiac surgery. Anesthesiol Clin North America 21 (2003) 511-526
5. Dalbert S., Ganter M.T., Furrer L., et al. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: In vitro comparison of two different point of care devices. Acta Anaesthesiol Scand 50 (2006) 461-468
6. Ganter M.T., Dalbert S., Graves K., et al. Monitoring activated clotting time for combined heparin and aprotinin application: An in vitro evaluation of a new aprotinin-insensitive test using SONOCLOT. Anesth Analg 101 (2005) 308-314
7. Ganter M.T., Monn A., Tavakoli R., et al. Monitoring activated clotting time for combined heparin and aprotinin application: In vivo evaluation of a new aprotinin-insensitive test using Sonoclot. Eur J Cardiothorac Surg 30 (2006) 278-284
8. Bland J.M., and Altman D.G. Comparing methods of measurement: Why plotting difference against standard method is misleading. Lancet 346 (1995) 1085-1087
9. Culliford A.T., Gitel S.N., Starr N., et al. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass. Ann Surg 193 (1981) 105-111
10. Leyvi G., Shore-Lesserson L., Harrington D., et al. An investigation of a new activated clotting time "MAX-ACT" in patients undergoing extracorporeal circulation. Anesth Analg 92 (2001) 578-583
11. Despotis G.J., Summerfield A.L., Joist J.H., et al. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. J Thorac Cardiovasc Surg 108 (1994) 1076-1082
12. Despotis G.J., Filos K.S., Levine V., et al. Aprotinin prolongs activated and nonactivated whole blood clotting time and potentiates the effect of heparin in vitro. Anesth Analg 82 (1996) 1126-1131
13. Moorehead M.T., Westengard J.C., and Bull B.S. Platelet involvement in the activated coagulation time of heparinized blood. Anesth Analg 63 (1984) 394-398
14. Linden M.D., Schneider M., and Erber W.N. Acute normovolemic hemodilution does not reduce antithrombin concentration for cardiac surgery. J Thromb Thrombolysis 17 (2004) 173-176
15. Despotis G.J., Levine V., Joist J.H., et al. Antithrombin III during cardiac surgery: Effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation. Anesth Analg 85 (1997) 498-506
16. Krulder J.W., Strebus A.F., Meinders A.E., et al. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro. Haemostasis 26 (1996) 85-89
17. Henry D.A., Moxey A.J., Carless P.A., et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2001) CD001886
18. Wendel H.P., Heller W., Gallimore M.J., et al. The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement. Blood Coagul Fibrinolysis 4 (1993) 41-45
19. Laurel M.T., Ratnoff O.D., and Everson B. Inhibition of the activation of Hageman factor (factor XII) by aprotinin (Trasylol). J Lab Clin Med 119 (1992) 580-585
20. Dietrich W., Dilthey G., Spannagl M., et al. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study. Anesthesiology 83 (1995) 679-689
21. Swartz M.F., Fink G.W., and Searles B. Aprotinin and hemostasis monitoring concerns during cardiac surgery. J Extra Corpor Technol 36 (2004) 375-383
22. Landis R.C., Asimakopoulos G., Poullis M., et al. The antithrombotic and antiinflammatory mechanisms of action of aprotinin. Ann Thorac Surg 72 (2001) 2169-2175
23. Dietrich W., and Jochum M. Effect of celite and kaolin on activated clotting time in the presence of aprotinin: Activated clotting time is reduced by binding of aprotinin to kaolin. J Thorac Cardiovasc Surg 109 (1995) 177-178
24. Hett D.A., Walker D., Pilkington S.N., et al. Sonoclot analysis. Br J Anaesth 75 (1995) 771-776
25. Tucci M.A., Ganter M.T., Hamiel C.R., et al. Platelet function monitoring with the Sonoclot analyzer after in vitro tirofiban and heparin administration. J Thorac Cardiovasc Surg 131 (2006) 1314-1322